Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
Study NCT ID:
NCT03356912
Status:
UNKNOWN
Last Update Posted:
2017-12-14
First Post:
2017-10-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy
Sponsor:
Consorzio Oncotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-05-04
Completion Date Type:
ESTIMATED
First Submit Date:
2017-10-26
First Submit QC Date:
None
Study First Post Date:
2017-11-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-13
Last Update Post Date:
2017-12-14
Last Update Post Date Type:
ACTUAL